What does CUSIP 03209R103 represent in this 13F holders report?

CUSIP 03209R103 is the security identifier for AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock in Q2 2022?

217 institutional investors reported AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH)

CUSIP: 03209R103

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 46,377,939
Total 13F shares: 30,557,166
Share change: +1,193,151
Total reported value: $1,062,910,134
Put/Call ratio: 1207%
Price per share: $34.79
Number of holders: 217
Value change: +$40,970,389
Number of buys: 121
Number of sells: 86

Quarterly Holders Quick Answers

What is CUSIP 03209R103?
CUSIP 03209R103 identifies AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 03209R103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	15%	7,103,524	$255,016,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	7.5%	3,487,430	$125,199,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	5.4%	2,483,205	$89,147,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	3.9%	1,796,269	$64,488,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	2.9%	1,321,951	$47,458,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	1.6%	733,837	$26,344,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.5%	703,479	$25,254,000	—	31 Mar 2022	13F
FULLER & THALER ASSET MANAGEMENT, INC.	13F	Company	1.3%	614,855	$22,073,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	1.2%	562,381	$20,188,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	1%	476,675	$16,899,000	—	31 Mar 2022	13F
Assenagon Asset Management S.A.	13F	Company	0.92%	427,605	$15,351,000	—	31 Mar 2022	13F
Richard Koo	3/4/5	Director	— mixed-class rows	286,471 mixed-class rows	$15,350,254	—	07 Jun 2021	3/4/5
NORTHERN TRUST CORP	13F	Company	0.87%	404,142	$14,509,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.87%	401,405	$14,409,000	—	31 Mar 2022	13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	13F	Company	0.84%	391,585	$14,058,000	—	31 Mar 2022	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.78%	363,504	$13,049,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.73%	339,347	$12,183,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.67%	308,700	$11,082,000	—	31 Mar 2022	13F
NORDEA INVESTMENT MANAGEMENT AB	13F	Company	0.61%	284,391	$10,426,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.58%	268,398	$9,636,000	—	31 Mar 2022	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.58%	266,904	$9,582,000	—	31 Mar 2022	13F
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income	13F	Company	0.54%	251,659	$9,035,000	—	31 Mar 2022	13F
FRONTIER CAPITAL MANAGEMENT CO LLC	13F	Company	0.54%	251,272	$9,021,000	—	31 Mar 2022	13F
SILVERCREST ASSET MANAGEMENT GROUP LLC	13F	Company	0.52%	241,701	$8,677,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	0.51%	237,883	$8,540,000	—	31 Mar 2022	13F
Hillsdale Investment Management Inc.	13F	Company	0.51%	234,338	$8,412,000	—	31 Mar 2022	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.4%	187,784	$6,741,000	—	31 Mar 2022	13F
Penserra Capital Management LLC	13F	Company	0.39%	178,801	$6,418,000	—	31 Mar 2022	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.38%	177,339	$6,366,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.37%	173,321	$6,222,000	—	31 Mar 2022	13F
FRIESS ASSOCIATES LLC	13F	Company	0.33%	154,415	$5,543,000	—	31 Mar 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.33%	154,339	$5,538,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.3%	140,229	$5,034,000	—	31 Mar 2022	13F
LSV ASSET MANAGEMENT	13F	Company	0.3%	139,753	$5,017,000	—	31 Mar 2022	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.3%	139,026	$4,991,033	—	31 Mar 2022	13F
Informed Momentum Co LLC	13F	Company	0.27%	124,697	$4,477,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.25%	116,488	$4,181,000	—	31 Mar 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.24%	112,516	$4,039,000	—	31 Mar 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.24%	110,148	$3,949,000	—	31 Mar 2022	13F
Clark Capital Management Group, Inc.	13F	Company	0.21%	95,629	$3,433,000	—	31 Mar 2022	13F
Calamos Advisors LLC	13F	Company	0.2%	94,643	$3,398,000	—	31 Mar 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.2%	94,070	$3,377,000	—	31 Mar 2022	13F
Global IMC LLC	13F	Company	0.2%	91,702	$3,292,000	—	31 Mar 2022	13F
Swiss National Bank	13F	Company	0.2%	90,500	$3,249,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.19%	88,468	$3,177,000	—	31 Mar 2022	13F
Legal & General Group Plc	13F	Company	0.19%	87,191	$3,130,000	—	31 Mar 2022	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.18%	83,136	$2,986,000	—	31 Mar 2022	13F
Allspring Global Investments Holdings, LLC	13F	Company	0.18%	82,053	$2,945,000	—	31 Mar 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.17%	80,876	$2,903,000	—	31 Mar 2022	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.17%	80,685	$2,896,000	—	31 Mar 2022	13F

Institutional Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q2 2022

As of 30 Jun 2022, Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) was held by 217 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,557,166 shares. The largest 10 holders included BlackRock Inc., FEDERATED HERMES, INC., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, MORGAN STANLEY, FULLER & THALER ASSET MANAGEMENT, INC., GEODE CAPITAL MANAGEMENT, LLC, Nuveen Asset Management, LLC, and Invesco Ltd.. This page lists 217 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

201

Q2 2022 holders

217

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.